Treatment with eFT-508 increases chemosensitivity in breast cancer cells by modulating the tumor microenvironment

BACKGROUND: Patients with triple-negative breast cancer (TNBC) are better responders to neoadjuvant chemotherapy; however, they are poor in the durability of response with decreased overall and progression-free survival. METHODS: Given that significant improvements have been reported with PD-L1-PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhao-ying, Jiang, Cheng-wei, Zhang, Wen-long, Sun, Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206753/
https://www.ncbi.nlm.nih.gov/pubmed/35717238
http://dx.doi.org/10.1186/s12967-022-03474-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206753/
https://www.ncbi.nlm.nih.gov/pubmed/35717238
http://dx.doi.org/10.1186/s12967-022-03474-9

Ejemplares similares